Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuts and Bolts of Relationship-Centered Communication in the Allergy Immunology Clinic.

The journal of allergy and clinical immunology. In practice·2026
Same author

When knowing costs too much: a health-economic evaluation of failed 95044 reimbursement for patch testing in allergic contact dermatitis.

The journal of allergy and clinical immunology. In practice·2026
Same author

Finding a Balance: Auricular Acupressure in the Allergy Clinic.

The journal of allergy and clinical immunology. In practice·2026
Same author

Balancing patient perspectives and evidence in food protein-induced enterocolitis syndrome (FPIES).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and Mindset.

The journal of allergy and clinical immunology. In practice·2026
Same author

Values-Based Healthcare and the Quintuple Aim: Connection, Compassion, Equity, & Stewardship.

The journal of allergy and clinical immunology. In practice·2026

Related Experiment Video

Updated: Jun 2, 2026

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

An update on hereditary angioedema.

Marylee Verdi1, Marcus Shaker

  • 1Emergency Department, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA. marcus.shaker@dartmouth.edu

Advanced Emergency Nursing Journal
|May 6, 2011
PubMed
Summary
This summary is machine-generated.

Hereditary angioedema (HAE) is a rare genetic disorder affecting C1 inhibitor levels or function. Treatments aim to restore C1 inhibitor or block bradykinin to manage swelling attacks.

Related Experiment Videos

Last Updated: Jun 2, 2026

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Area of Science:

  • Immunology
  • Genetics
  • Pharmacology

Background:

  • Hereditary angioedema (HAE) affects ~1 in 50,000 individuals globally.
  • It is characterized by C1 inhibitor deficiency (Type I) or dysfunction (Type II).
  • HAE causes recurrent swelling in the face, extremities, GI tract, and larynx.

Observation:

  • Patients experience unpredictable angioedema episodes.
  • These attacks can be debilitating and life-threatening if the larynx is involved.

Findings:

  • Treatment strategies focus on increasing C1 inhibitor levels.
  • Therapies include stimulating endogenous pathways or exogenous C1 inhibitor supplementation.
  • Bradykinin inhibition offers another therapeutic approach for acute attacks.

Implications:

  • Effective management of HAE involves addressing both acute episodes and prophylaxis.
  • Targeted therapies improve patient quality of life and reduce disease burden.
  • Further research into C1 inhibitor pathways and bradykinin modulation is crucial.